HUP9802303A3 - Calcitriol derivatives and their uses - Google Patents

Calcitriol derivatives and their uses

Info

Publication number: HUP9802303A3
Authority: HU; Hungary
Prior art keywords: calcitriol derivatives; calcitriol; derivatives
Prior art date: 1995-09-21

Application number

HU9802303A

Other languages

Hungarian (hu)

Original Assignee

Wisconsin Alumni Res Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-09-21

Filing date

1996-09-20

Publication date

1999-05-28

1995-09-21 Priority claimed from US08/531,403 external-priority patent/US5952317A/en

1996-09-20 Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found

1999-02-01 Publication of HUP9802303A2 publication Critical patent/HUP9802303A2/en

1999-05-28 Publication of HUP9802303A3 publication Critical patent/HUP9802303A3/en

Links

150000001668 calcitriol derivatives Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid

HU9802303A 1995-09-21 1996-09-20 Calcitriol derivatives and their uses HUP9802303A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US53186795A	1995-09-21	1995-09-21
US08/531,403 US5952317A (en)	1995-09-21	1995-09-21	Calcitriol derivatives and their uses

Publications (2)

Publication Number	Publication Date
HUP9802303A2 HUP9802303A2 (en)	1999-02-01
HUP9802303A3 true HUP9802303A3 (en)	1999-05-28

Family

ID=27063537

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU9802303A HUP9802303A3 (en)	1995-09-21	1996-09-20	Calcitriol derivatives and their uses

Country Status (9)

Country	Link
EP (1)	EP1021401A1 (en)
JP (1)	JP3372259B2 (en)
KR (1)	KR100327922B1 (en)
AU (1)	AU717238B2 (en)
CA (1)	CA2229316C (en)
HU (1)	HUP9802303A3 (en)
NO (1)	NO981282L (en)
NZ (2)	NZ319819A (en)
WO (1)	WO1997011053A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU5305600A (en) *	1999-08-17	2001-03-13	Wisconsin Alumni Research Foundation	Animal feed containing hydrolyzable calcitriol derivatives
KR100317935B1 (en) *	1999-10-20	2001-12-22	유승필	Pharmaceutical compositions and preparations for treatment of metabolic bone disease
US20020045606A1 (en)	1999-12-02	2002-04-18	Reddy Satyanarayana G.	Esters of vitamin D3 and uses thereof
US20030195175A1 (en) *	2002-03-25	2003-10-16	Deluca Hector F.	Use of carbon-2-modified-vitamin D analogs to induce the formation of new bone
BRPI0508333A (en)	2004-03-01	2007-07-17	Bioxell Spa	use of a vitamin d compound, method of preventing and / or treating interstitial cystitis, pharmaceutical formulation, vitamin d compound, and kit
CA2586679A1 (en)	2004-11-12	2006-05-18	Bioxell Spa	Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
DK1993559T3 (en)	2006-02-03	2016-10-03	Opko Renal Llc	Treatment of vitamin D deficiency and MALFUNCTION with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
SI2037936T1 (en)	2006-06-21	2014-11-28	Opko Renal, Llc	Method of treating and preventing secondary hyperparathyroidism
US11752158B2 (en)	2007-04-25	2023-09-12	Eirgen Pharma Ltd.	Method of treating vitamin D insufficiency and deficiency
CA2683514C (en)	2007-04-25	2019-07-09	Proventiv Therapeutics, Llc	Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
WO2008134518A2 (en)	2007-04-25	2008-11-06	Cytochroma Inc.	Methods and compounds for vitamin d therapy
KR20190141269A (en)	2007-04-25	2019-12-23	사이토크로마 인코포레이티드	Oral controlled release compositions comprising vitamin d compound and waxy carrier
CN106853250A (en)	2008-04-02	2017-06-16	赛特克罗公司	Method, composition, purposes and kit for vitamin D deficiency and associated disorders
RS60087B1 (en)	2010-03-29	2020-05-29	Opko Ireland Global Holdings Ltd	Methods and compositions for reducing parathyroid levels
KR101847947B1 (en)	2013-03-15	2018-05-28	옵코 아이피 홀딩스 Ⅱ 인코포레이티드	Stabilized modified release vitamin d formulation
CN114681468A (en)	2014-08-07	2022-07-01	欧普科爱尔兰环球控股有限公司	Adjunctive therapy with 25-hydroxyvitamin D
CN108883120A (en)	2016-03-28	2018-11-23	欧普科爱尔兰环球控股有限公司	Vitamin D treatment method
KR101983654B1 (en) *	2018-07-24	2019-05-29	한국과학기술원	Therapeutic composition capable of alleviating the inhibition of development of CFC syndrome patients
CN114681467B (en) *	2022-03-30	2024-03-12	南通华山药业有限公司	Application of alfacalcidol heterocyclic ester derivative in preparation of antitumor drugs
CN114656413B (en) *	2022-03-30	2024-04-09	南通华山药业有限公司	Alfacalcidol heterocyclic ester derivative and preparation method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4195027A (en) *	1978-01-16	1980-03-25	Wisconsin Alumni Research Foundation	Process for preparing 1α-hydroxylated compounds
US4206131A (en) *	1978-06-19	1980-06-03	The Upjohn Company	Compounds and process
US4188345A (en) *	1978-07-26	1980-02-12	Wisconsin Alumni Research Foundation	Fluorovitamin D compounds and processes for their preparation
JPS5846508A (en) *	1981-09-14	1983-03-18	日本石油化学株式会社	Conductive material and method of producing same
IE55801B1 (en) *	1982-07-26	1991-01-16	Wisconsin Alumni Res Found	Novel vitamin d analogs
JPH0825993B2 (en) *	1990-08-20	1996-03-13	大同ほくさん株式会社	Method for producing vitamin D2 and D3 or active vitamin D2 and D3, and intermediate thereof
JPH05339230A (en) *	1992-03-12	1993-12-21	Nisshin Flour Milling Co Ltd	Activated type vitamin d2 and the production of its derivative
JP3182215B2 (en) *	1992-06-26	2001-07-03	日清製粉株式会社	1-acyloxyvitamin D derivative

1996
- 1996-09-20 NZ NZ319819A patent/NZ319819A/en unknown
- 1996-09-20 EP EP96933853A patent/EP1021401A1/en not_active Withdrawn
- 1996-09-20 JP JP51294597A patent/JP3372259B2/en not_active Expired - Fee Related
- 1996-09-20 AU AU72426/96A patent/AU717238B2/en not_active Ceased
- 1996-09-20 NZ NZ501318A patent/NZ501318A/en unknown
- 1996-09-20 HU HU9802303A patent/HUP9802303A3/en unknown
- 1996-09-20 KR KR1019980702077A patent/KR100327922B1/en not_active IP Right Cessation
- 1996-09-20 CA CA002229316A patent/CA2229316C/en not_active Expired - Fee Related
- 1996-09-20 WO PCT/US1996/015184 patent/WO1997011053A1/en not_active Application Discontinuation
1998
- 1998-03-20 NO NO981282A patent/NO981282L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2229316A1 (en)	1997-03-27
JP3372259B2 (en)	2003-01-27
CA2229316C (en)	2005-04-12
WO1997011053A1 (en)	1997-03-27
MX9801943A (en)	1998-08-30
EP1021401A1 (en)	2000-07-26
AU717238B2 (en)	2000-03-23
NO981282L (en)	1998-05-22
HUP9802303A2 (en)	1999-02-01
AU7242696A (en)	1997-04-09
KR19990063628A (en)	1999-07-26
NZ319819A (en)	2000-02-28
KR100327922B1 (en)	2002-05-09
NZ501318A (en)	2001-07-27
NO981282D0 (en)	1998-03-20
JPH11511475A (en)	1999-10-05

Publication	Publication Date	Title
GB2298422B (en)	1997-01-29	Compounds and their use
IL122428A0 (en)	1998-06-15	Minizymes and minribozymes and uses thereof
HUP9802303A3 (en)	1999-05-28	Calcitriol derivatives and their uses
EP0836617A4 (en)	2000-06-28	Parevins and tachytegrins
ZA964862B (en)	1997-01-07	Optimized minizymes and miniribozymes and uses thereof
EP0744125A3 (en)	1997-04-16	Iodo-complex and its use
GB9526407D0 (en)	1996-02-21	Substances and their uses
AP9600802A0 (en)	1996-04-30	Libricant
ZA965962B (en)	1997-01-31	Anti-piroplasmotic agent
AU1105P (en)	1998-09-23	DALESE Metrosideros excelsus
GB9515484D0 (en)	1995-09-27	Substances and their uses
GB9515482D0 (en)	1995-09-27	Substances and their uses
GB9515483D0 (en)	1995-09-27	Substances and their uses
GB9504258D0 (en)	1995-04-19	Substances and their uses
GB9512325D0 (en)	1995-08-16	Substances and their uses
GB9512319D0 (en)	1995-08-16	Substances and their uses
GB9501010D0 (en)	1995-03-08	Substances and their uses
GB9507541D0 (en)	1995-05-31	Substances and their uses
GB9510392D0 (en)	1995-07-19	Substances and their uses
GB9500898D0 (en)	1995-03-08	Substances and their uses
PL307196A1 (en)	1996-08-19	Pharmaceutcal agent
AU129273S (en)	1997-02-25	Pendant
AU125850S (en)	1996-02-13	Tea - towel
AU125678S (en)	1996-01-22	Sandboard
AU125851S (en)	1996-02-13	Tea - towel